VICTORIA CHAPMAN: Open Payments
NPI 1073355251 · MINDEN, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,444 in 117 payments from 32 companies in 2025. Trend: 2023 $0 · 2024 $1,239 · 2025 $2,444
Food & beverage: $2,260Education: $184
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $398 |
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $214 |
| Incyte Corporation | 8 | $212 |
| Novartis Pharmaceuticals Corporation | 10 | $174 |
| Genentech USA, Inc. | 8 | $150 |
| AstraZeneca Pharmaceuticals LP | 7 | $142 |
| E.R. Squibb & Sons, L.L.C. | 6 | $107 |
| Regeneron Healthcare Solutions, Inc. | 4 | $86 |
| Eisai Inc. | 4 | $84 |
| Pharmacosmos Therapeutics Inc. | 4 | $80 |
Products named: ERLEADA, Nubeqa, RYBREVANT, OPDIVO, Polivy, Lenvima, MONOFERRIC, TALVEY.
Industry payments across LA — which companies pay providers there.
